Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24568613)

1.

Effect of inhaled endotoxin on mucociliary clearance and airway inflammation in mild smokers and nonsmokers.

Bennett WD, Alexis NE, Almond M, Herbst M, Zeman KL, Peden DB.

J Aerosol Med Pulm Drug Deliv. 2014 Dec;27(6):459-65. doi: 10.1089/jamp.2013.1089.

PMID:
24568613
2.

Effect of inhaled dust mite allergen on regional particle deposition and mucociliary clearance in allergic asthmatics.

Bennett WD, Herbst M, Alexis NE, Zeman KL, Wu J, Hernandez ML, Peden DB.

Clin Exp Allergy. 2011 Dec;41(12):1719-28. doi: 10.1111/j.1365-2222.2011.03814.x. Epub 2011 Jul 5.

3.

IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers.

Hernandez ML, Mills K, Almond M, Todoric K, Aleman MM, Zhang H, Zhou H, Peden DB.

J Allergy Clin Immunol. 2015 Feb;135(2):379-85. doi: 10.1016/j.jaci.2014.07.039. Epub 2014 Sep 5.

PMID:
25195169
4.

Atopic asthmatic patients have reduced airway inflammatory cell recruitment after inhaled endotoxin challenge compared with healthy volunteers.

Hernandez ML, Herbst M, Lay JC, Alexis NE, Brickey WJ, Ting JP, Zhou H, Peden DB.

J Allergy Clin Immunol. 2012 Oct;130(4):869-76.e2. doi: 10.1016/j.jaci.2012.05.026. Epub 2012 Jul 4.

5.

Effects of ozone on normal and potentially sensitive human subjects. Part II: Airway inflammation and responsiveness to ozone in nonsmokers and smokers.

Frampton MW, Morrow PE, Torres A, Voter KZ, Whitin JC, Cox C, Speers DM, Tsai Y, Utell MJ.

Res Rep Health Eff Inst. 1997 Jun;(78):39-72; discussion 81-99.

PMID:
9387196
6.

Development of an inhaled endotoxin challenge protocol for characterizing evoked cell surface phenotype and genomic responses of airway cells in allergic individuals.

Alexis NE, Brickey WJ, Lay JC, Wang Y, Roubey RA, Ting JP, Peden DB.

Ann Allergy Asthma Immunol. 2008 Mar;100(3):206-15. doi: 10.1016/S1081-1206(10)60444-9.

PMID:
18426139
7.

Smoking and airway inflammation in patients with mild asthma.

Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC.

Chest. 2001 Dec;120(6):1917-22.

PMID:
11742922
8.
9.

Bacterial endotoxin is an active component of cigarette smoke.

Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W.

Chest. 1999 Mar;115(3):829-35.

PMID:
10084499
10.

Vitamin E, γ-tocopherol, reduces airway neutrophil recruitment after inhaled endotoxin challenge in rats and in healthy volunteers.

Hernandez ML, Wagner JG, Kala A, Mills K, Wells HB, Alexis NE, Lay JC, Jiang Q, Zhang H, Zhou H, Peden DB.

Free Radic Biol Med. 2013 Jul;60:56-62. doi: 10.1016/j.freeradbiomed.2013.02.001. Epub 2013 Feb 9.

11.

Nasal Mucociliary Clearance in Subjects With COPD After Smoking Cessation.

Ito JT, Ramos D, Lima FF, Rodrigues FM, Gomes PR, Moreira GL, Macchione M, Toledo AC, Ramos EM.

Respir Care. 2015 Mar;60(3):399-405. doi: 10.4187/respcare.03266. Epub 2014 Nov 11.

PMID:
25389352
12.

Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers.

Alexis NE, Lay JC, Haczku A, Gong H, Linn W, Hazucha MJ, Harris B, Tal-Singer R, Peden DB.

Environ Health Perspect. 2008 Jun;116(6):799-805. doi: 10.1289/ehp.10981.

13.

Mucociliary clearance in patients with chronic asthma: effects of beta agonists.

Daviskas E, Anderson SD, Shaw J, Eberl S, Seale JP, Yang IA, Young IH.

Respirology. 2005 Sep;10(4):426-35.

PMID:
16135164
14.
15.

Airway vascular endothelial function in healthy smokers without systemic endothelial dysfunction.

Mendes ES, Cancado JE, Rebolledo P, Arana J, Parker M, Gonzalez A, Hurwitz BE, Wanner A.

Chest. 2013 Jun;143(6):1733-9. doi: 10.1378/chest.12-1033.

PMID:
23348843
16.

Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development.

Janssen O, Schaumann F, Holz O, Lavae-Mokhtari B, Welker L, Winkler C, Biller H, Krug N, Hohlfeld JM.

BMC Pulm Med. 2013 Mar 28;13:19. doi: 10.1186/1471-2466-13-19.

17.

Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy.

Michel O, Dentener M, Corazza F, Buurman W, Rylander R.

J Allergy Clin Immunol. 2001 May;107(5):797-804.

PMID:
11344345
19.

Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects.

Aul R, Armstrong J, Duvoix A, Lomas D, Hayes B, Miller BE, Jagger C, Singh D.

Br J Clin Pharmacol. 2012 Dec;74(6):1023-32. doi: 10.1111/j.1365-2125.2012.04287.x.

20.

Nasal PMN response to repeated challenge with endotoxin in healthy volunteers.

Doreswamy V, Alexis NE, Zhou H, Peden DB.

Inhal Toxicol. 2011 Feb;23(3):142-7. doi: 10.3109/08958378.2011.553247.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk